A year after Australia took the very bold step of approving psychotomimetic drugs (drugs that mimic psychosis, known in polite circles as ‘psychedelics’) to assist in psychotherapy, an advisory panel for the US Food and Drug Administration (FDA) did not approve the use of MDMA (methylenedioxymethamphetamine) in PTSD. The science is just not there, the…
Keep reading with a 7-day free trial
Subscribe to Niall McLaren on Critical Psychiatry to keep reading this post and get 7 days of free access to the full post archives.